132 related articles for article (PubMed ID: 36737667)
1. Author Correction: Screening for CD19-specific chimaeric antigen receptors with enhanced signalling via a barcoded library of intracellular domains.
Gordon KS; Kyung T; Perez CR; Holec PV; Ramos A; Zhang AQ; Agarwal Y; Liu Y; Koch CE; Starchenko A; Joughin BA; Lauffenburger DA; Irvine DJ; Hemann MT; Birnbaum ME
Nat Biomed Eng; 2023 Apr; 7(4):599-602. PubMed ID: 36737667
[No Abstract] [Full Text] [Related]
2. Screening for CD19-specific chimaeric antigen receptors with enhanced signalling via a barcoded library of intracellular domains.
Gordon KS; Kyung T; Perez CR; Holec PV; Ramos A; Zhang AQ; Agarwal Y; Liu Y; Koch CE; Starchenko A; Joughin BA; Lauffenburger DA; Irvine DJ; Hemann MT; Birnbaum ME
Nat Biomed Eng; 2022 Jul; 6(7):855-866. PubMed ID: 35710755
[TBL] [Abstract][Full Text] [Related]
3. CD28 co-stimulation via tumour-specific chimaeric receptors induces an incomplete activation response in Epstein-Barr virus-specific effector memory T cells.
Altvater B; Pscherer S; Landmeier S; Niggemeier V; Juergens H; Vormoor J; Rossig C
Clin Exp Immunol; 2006 Jun; 144(3):447-57. PubMed ID: 16734614
[TBL] [Abstract][Full Text] [Related]
4. Refining chimeric antigen receptors via barcoded protein domain combination pooled screening.
Rios X; Pardias O; Morales MA; Bhattacharya P; Chen Y; Guo L; Zhang C; Di Pierro EJ; Tian G; Barragan GA; Sumazin P; Metelitsa LS
Mol Ther; 2023 Nov; 31(11):3210-3224. PubMed ID: 37705245
[TBL] [Abstract][Full Text] [Related]
5. Exploration of the lysis mechanisms of leukaemic blasts by chimaeric T-cells.
Laurin D; Marin V; Biagi E; Pizzitola I; Agostoni V; Gallot G; Vié H; Jacob MC; Chaperot L; Aspord C; Plumas J
J Biomed Biotechnol; 2010; 2010():234540. PubMed ID: 20617141
[TBL] [Abstract][Full Text] [Related]
6. Parameters of long-term response with CD28-based CD19 chimaeric antigen receptor-modified T cells in children and young adults with B-acute lymphoblastic leukaemia.
Jacoby E; Bielorai B; Hutt D; Itzhaki O; Adam E; Bar D; Besser MJ; Toren A
Br J Haematol; 2022 May; 197(4):475-481. PubMed ID: 35224724
[TBL] [Abstract][Full Text] [Related]
7. Development of a chimaeric receptor approach to study signalling by tumour necrosis factor receptor family members.
Xu D; Shi Z; McDonald J; Pan G; Cao X; Yu X; Feng X
Biochem J; 2004 Oct; 383(Pt 2):219-25. PubMed ID: 15250821
[TBL] [Abstract][Full Text] [Related]
8. CD19 differentially regulates BCR signalling through the recruitment of PI3K.
Xu Y; Fairfax K; Light A; Huntington ND; Tarlinton DM
Autoimmunity; 2014 Nov; 47(7):430-7. PubMed ID: 24953501
[TBL] [Abstract][Full Text] [Related]
9. A CD19/Fc fusion protein for detection of anti-CD19 chimeric antigen receptors.
De Oliveira SN; Wang J; Ryan C; Morrison SL; Kohn DB; Hollis RP
J Transl Med; 2013 Jan; 11():23. PubMed ID: 23360526
[TBL] [Abstract][Full Text] [Related]
10. Combined 4-1BB and ICOS co-stimulation improves anti-tumor efficacy and persistence of dual anti-CD19/CD20 chimeric antigen receptor T cells.
Wang Y; Zhong K; Ke J; Chen X; Chen Y; Shu W; Chen C; Hu S; Sun X; Huang H; Luo C; Liu L; Yang J; Zhang Y; Zhi H
Cytotherapy; 2021 Aug; 23(8):715-723. PubMed ID: 33863641
[TBL] [Abstract][Full Text] [Related]
11. Function of Novel Anti-CD19 Chimeric Antigen Receptors with Human Variable Regions Is Affected by Hinge and Transmembrane Domains.
Alabanza L; Pegues M; Geldres C; Shi V; Wiltzius JJW; Sievers SA; Yang S; Kochenderfer JN
Mol Ther; 2017 Nov; 25(11):2452-2465. PubMed ID: 28807568
[TBL] [Abstract][Full Text] [Related]
12. Human gammadelta T cells as mediators of chimaeric-receptor redirected anti-tumour immunity.
Rischer M; Pscherer S; Duwe S; Vormoor J; Jürgens H; Rossig C
Br J Haematol; 2004 Aug; 126(4):583-92. PubMed ID: 15287953
[TBL] [Abstract][Full Text] [Related]
13. Retargeting CD19 Chimeric Antigen Receptor T Cells via Engineered CD19-Fusion Proteins.
Klesmith JR; Su L; Wu L; Schrack IA; Dufort FJ; Birt A; Ambrose C; Hackel BJ; Lobb RR; Rennert PD
Mol Pharm; 2019 Aug; 16(8):3544-3558. PubMed ID: 31242389
[TBL] [Abstract][Full Text] [Related]
14. T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial.
Lee DW; Kochenderfer JN; Stetler-Stevenson M; Cui YK; Delbrook C; Feldman SA; Fry TJ; Orentas R; Sabatino M; Shah NN; Steinberg SM; Stroncek D; Tschernia N; Yuan C; Zhang H; Zhang L; Rosenberg SA; Wayne AS; Mackall CL
Lancet; 2015 Feb; 385(9967):517-528. PubMed ID: 25319501
[TBL] [Abstract][Full Text] [Related]
15. [Construction of camelidae natural nanobody phage dispaly library and screening, production and identification of anti-CD19 nanobody].
Li G; Li Y; Chu Y; Zhang A; Pan J; Wang H; Xu G
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Nov; 36(11):1036-1043. PubMed ID: 33210599
[TBL] [Abstract][Full Text] [Related]
16. Rapid parallel generation of a fluorescently barcoded drop library from a microtiter plate using the plate-interfacing parallel encapsulation (PIPE) chip.
Zath GK; Sperling RA; Hoffman CW; Bikos DA; Abbasi R; Abate AR; Weitz DA; Chang CB
Lab Chip; 2022 Nov; 22(23):4735-4745. PubMed ID: 36367139
[TBL] [Abstract][Full Text] [Related]
17. The CD19 signalling molecule is elevated in NOD mice and controls type 1 diabetes development.
Ziegler AI; Le Page MA; Maxwell MJ; Stolp J; Guo H; Jayasimhan A; Hibbs ML; Santamaria P; Miller JF; Plebanski M; Silveira PA; Slattery RM
Diabetologia; 2013 Dec; 56(12):2659-68. PubMed ID: 24013782
[TBL] [Abstract][Full Text] [Related]
18. Construction, expression and characterization of chimaeric toxins containing the ribonucleolytic toxin restrictocin: intracellular mechanism of action.
Rathore D; Batra JK
Biochem J; 1997 Jun; 324 ( Pt 3)(Pt 3):815-22. PubMed ID: 9210405
[TBL] [Abstract][Full Text] [Related]
19. Author Correction: Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma.
Brudno JN; Lam N; Vanasse D; Shen YW; Rose JJ; Rossi J; Xue A; Bot A; Scholler N; Mikkilineni L; Roschewski M; Dean R; Cachau R; Youkharibache P; Patel R; Hansen B; Stroncek DF; Rosenberg SA; Gress RE; Kochenderfer JN
Nat Med; 2020 May; 26(5):803. PubMed ID: 32291416
[TBL] [Abstract][Full Text] [Related]
20. Selecting costimulatory domains for chimeric antigen receptors: functional and clinical considerations.
Weinkove R; George P; Dasyam N; McLellan AD
Clin Transl Immunology; 2019; 8(5):e1049. PubMed ID: 31110702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
